A single-nucleotide polymorphism in MMP9 is associated with decreased risk of steroid-induced osteonecrosis of the femoral head

Oncotarget. 2016 Oct 18;7(42):68434-68441. doi: 10.18632/oncotarget.12034.

Abstract

Osteonecrosis of the femoral head (ONFH) is a common hip joint disease, and steroid-induced ONFH accounts for a large number of cases. Here, we examined eight previously-identified single-nucleotide polymorphisms (SNPs) in the MPP2 and MPP9 genes of 285 steroid-induced ONFH patients and 507 healthy controls from northern China to determine whether these SNPs were associated with the risk of developing steroid-induced ONFH. Chi-squared tests and genetic model and haplotype analyses were used to evaluate associations. The rs2274755 SNP in MMP9 was associated with a decreased risk of steroid-induced ONFH in the allele, dominant, and additive models. Additionally, the "CGC" MMP9 haplotype was associated with a 0.69-fold decrease in the risk of steroid-induced ONFH. Although additional, larger population-based studies are needed to confirm these findings, our results reveal for the first time an association between a MMP9 SNP at the rs2274755 locus and a decreased risk of steroid-induced ONFH in a northern Chinese population.

Keywords: MMP2; MMP9; association study; osteonecrosis of the femoral head; single nucleotide polymorphisms.

MeSH terms

  • Adult
  • Alleles
  • Asian People / genetics
  • China
  • Female
  • Femur Head Necrosis / chemically induced
  • Femur Head Necrosis / ethnology
  • Femur Head Necrosis / genetics*
  • Gene Frequency
  • Genetic Predisposition to Disease / ethnology
  • Genetic Predisposition to Disease / genetics*
  • Genotype
  • Haplotypes
  • Humans
  • Male
  • Matrix Metalloproteinase 9 / genetics*
  • Middle Aged
  • Polymorphism, Single Nucleotide*
  • Risk Factors
  • Steroids

Substances

  • Steroids
  • Matrix Metalloproteinase 9